151 related articles for article (PubMed ID: 32435012)
1. Myostatin: The Missing Link between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease?
Morioka T
J Atheroscler Thromb; 2020 Oct; 27(10):1036-1038. PubMed ID: 32435012
[No Abstract] [Full Text] [Related]
2. Myostatin and sarcopenia: opportunities and challenges - a mini-review.
White TA; LeBrasseur NK
Gerontology; 2014; 60(4):289-93. PubMed ID: 24457615
[TBL] [Abstract][Full Text] [Related]
3. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.
Consitt LA; Clark BC
J Frailty Aging; 2018; 7(1):21-27. PubMed ID: 29412438
[TBL] [Abstract][Full Text] [Related]
4. Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.
Avin KG; Moorthi RN
Curr Osteoporos Rep; 2015 Jun; 13(3):173-9. PubMed ID: 25691218
[TBL] [Abstract][Full Text] [Related]
5. Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications.
Barbalho SM; Flato UAP; Tofano RJ; Goulart RA; Guiguer EL; Detregiachi CRP; Buchaim DV; Araújo AC; Buchaim RL; Reina FTR; Biteli P; Reina DOBR; Bechara MD
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443765
[TBL] [Abstract][Full Text] [Related]
6. Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study.
Lee SM; Han MY; Kim SH; Cha RH; Kang SH; Kim JC; An WS
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287929
[TBL] [Abstract][Full Text] [Related]
7. TGF-β superfamily signaling in muscle and tendon adaptation to resistance exercise.
Gumucio JP; Sugg KB; Mendias CL
Exerc Sport Sci Rev; 2015 Apr; 43(2):93-9. PubMed ID: 25607281
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of sarcopenia and cachexia: recent research advances.
Sakuma K; Aoi W; Yamaguchi A
Pflugers Arch; 2017 Jun; 469(5-6):573-591. PubMed ID: 28101649
[TBL] [Abstract][Full Text] [Related]
9. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.
Camporez JP; Petersen MC; Abudukadier A; Moreira GV; Jurczak MJ; Friedman G; Haqq CM; Petersen KF; Shulman GI
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2212-7. PubMed ID: 26858428
[TBL] [Abstract][Full Text] [Related]
10. Healthy community-living older men differ from women in associations between myostatin levels and skeletal muscle mass.
Peng LN; Lee WJ; Liu LK; Lin MH; Chen LK
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):635-642. PubMed ID: 29654636
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in aging and current strategies to counteract sarcopenia.
Sakuma K; Yamaguchi A
Curr Aging Sci; 2010 Jul; 3(2):90-101. PubMed ID: 20158492
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia: a histological and immunohistochemical study on age-related muscle impairment.
Tarantino U; Scimeca M; Piccirilli E; Tancredi V; Baldi J; Gasbarra E; Bonanno E
Aging Clin Exp Res; 2015 Oct; 27 Suppl 1():S51-60. PubMed ID: 26197719
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.
Verzola D; Barisione C; Picciotto D; Garibotto G; Koppe L
Kidney Int; 2019 Mar; 95(3):506-517. PubMed ID: 30598193
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions.
Watanabe H; Enoki Y; Maruyama T
Biol Pharm Bull; 2019; 42(9):1437-1445. PubMed ID: 31474705
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta and myostatin signaling in skeletal muscle.
Kollias HD; McDermott JC
J Appl Physiol (1985); 2008 Mar; 104(3):579-87. PubMed ID: 18032576
[TBL] [Abstract][Full Text] [Related]
16. Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney Disease.
Avin KG; Chen NX; Organ JM; Zarse C; O'Neill K; Conway RG; Konrad RJ; Bacallao RL; Allen MR; Moe SM
PLoS One; 2016; 11(8):e0159411. PubMed ID: 27486747
[TBL] [Abstract][Full Text] [Related]
17. Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD.
Roshanravan B; Gamboa J; Wilund K
Am J Kidney Dis; 2017 Jun; 69(6):837-852. PubMed ID: 28427790
[TBL] [Abstract][Full Text] [Related]
18. [Myostatin - a modern understanding of the physiological role and significance in the development of age-associated diseases.].
Gazdanova AA; Kukes VG; Parfenova OK; Sidorov NG; Perkov AV; Solovieva SA; Ryazantceva OV; Lenkova NI
Adv Gerontol; 2021; 34(5):701-706. PubMed ID: 34998007
[TBL] [Abstract][Full Text] [Related]
19. [Role of myostatin in wasting syndrome associated with chronic diseases].
Zamora E; Galán A; Simó R
Med Clin (Barc); 2008 Nov; 131(15):585-90. PubMed ID: 19080842
[TBL] [Abstract][Full Text] [Related]
20. Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease.
Esposito P; Verzola D; Porta E; Milanesi S; Grignano MA; Avella A; Gregorini M; Abelli M; Ticozzelli E; Rampino T; Garibotto G
J Atheroscler Thromb; 2020 Oct; 27(10):1039-1052. PubMed ID: 32173683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
